drugset / Trial / NCT01100294

Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children

NCT01100294 ↗

Non-randomizedSingle-groupOpen-labelPrevention

Summary

To determine the tolerability and safety of FLUVAL P monovalent influenza vaccine in children.

Timeline

Start
2009-09
Primary completion
2010-04
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluval P Vaccine 3 ug —
Subject Fluval P Vaccine 0.25 ml —

Indications